![]() Olink Olink Proteomics is a company providing products and services for human protein biomarker discovery. | ![]() SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. | Otsuka Novel Products Otsuka Novel Products (ONPG) is a company dedicated to research and development of solutions for tuberculosis. | IMIDomics IMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients. | |
Founding Date | Founding Date 2004 | Founding Date 2000 | Founding Date N/A | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Uppsala, SE HQ Barcelona, ES Uppsala, SE Watertown, US | Locations Boulder, US HQ | Locations München, DE HQ | Locations HQ |
Employees | Employees 582 | Employees 483 | Employees 323% increase | Employees 3 |
Financial | ||||
Revenue (est.) | Revenue (est.) $169.6m (FY, 2023) | Revenue (est.) $97.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($31.6m) (FY, 2023) | Net income ($109.2m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 622.5m | Total funding raised N/A | Total funding raised $ 16.5m |

SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View companyOtsuka Novel Products (ONPG) is a company dedicated to research and development of solutions for tuberculosis.
View companyIMIDomics is a company that develops medicine diagnostics and therapeutics to optimize treatment of IMID (immune-mediated inflammatory diseases) patients.
View company